The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
I had hoped that vlad and hemo had learnt that this silence is not good for hemo ... they continue to keep us in vacuum
So much potential but absolutely rubbish leadership, no marketing, no awareness of the great science ... could be a long and painful wait in 2024 !!!
Checkricky ... you are so right. Its the same every morning ... a few manipulators sell early, create red and then hope the majority will follow. Luckily this is the time when LTHs have been waiting for and most are holding.
We know news could come anytime on trials or any other progress on licencing. Ignore the noise, the FUD and just wait for the rockets to launch !!!
SSccs ... Whether I am bipolar or not and that is irrelevant to where we are with Hemo at this stage. Shorters have destroyed the stock, we are in now nearly 7 weeks since IND was approved, we are fully funded for trials ... its now just a waiting game and buys (Albeit low volume) will start to increase as days pass by.
Ignore what has happened and focus on what will happen ... trials, news on CBR, CDX, licencing ... and at a MCAP of £20m !!!! This is an absolute steal.
2 options for all :-
1) Ignore the rubbish and negativity on LSE- and average down
2) Sell and focus on other stock
Irrespective, moaning and complaining on here makes zero difference. Vlad doesnt listen to anyone on here. He will release news in his own pace and we don't know what or when that will be but it is highly probably with all the bad news out, it will be massive for hemo. This stock has plenty of risk and that's why the price is sitting at 1.7p but this is not the 1st time this happened so best to just focus on easter and wait for news.
For those who are impatient, keep sending emails to Vlad and requesting regular updates as that is all we want and will create buying impetus. No news = no rerate here !!!!
This is all a game for the shorters ... One day it will explode on news. Until then buy and average down or just go away and come back at the end of the week. Painful yes but we know trials are imminent !!!!
It was 9th Feb when we got FDA approval. It is now now nearly 7 weeks and discussions must be very advanced so we should hear soon on trial dates and patients being injected. People waiting till the last moment before the RNS hits the street will lose out. Exciting times now sentiment is changing and only a few silly shorters still remain !!!
Https://www.jnj.com/media-center/press-releases/janssen-enters-worldwide-collaboration-and-license-agreement-with-cellular-biomedicine-group-to-develop-next-generation-car-t-therapies Phase 1 245m up front
https://legendbiotech.com/legend-news/legend-biotech-announces-exclusive-global-license-agreement-for-certain-car-t-therapies-targeting-dll3/ - Phase 1, 100m up front and 1b in milestones.
Please take it up with SP Angel who have done similar, not hard to google Clinical Phase 1 or PRE-clinical Oncology and things like CAR-T or bispecific antibodies etc. If you wish to go find companies similar for a lower mCap please dont let me stop you! Also while you are doing that look at the percentages of ownership of the IP, amount of debt, warrants issued etc.
And then if you wish you can easily find licencing deals for CAR-T treatments, you can find licencing deals at NDA level, Phase 1/2 and 3 and pre-clinical. Again I would invite you to find any CAR-T oncology related licensing deals where the valuation is LESS than the entire mCap of Hemogenyx. It is not rocket science, if the majority of licencing deals are in the 500m -1bn range for CAR-T in oncology and Hemo are valued at 35mil... there is a bit of disjoint there, not sure how you can argue anything different? These are numbers that everyone on this board can validate themselves. You might say that some are at a more advanced stage? Fair enough, but explain how so many pharma are attracting 100s of millions at pre-IPO/pre-clinical stages: https://www.insights.bio/cell-and-gene-therapy-insights/journal/article/482/Unlocking-the-therapeutic-and-commercial-potential-of-CAR-T-technology
Volumes are so thin that any buys are quickly cancelled with sellers to create red ... This is all a game and yes we all need to be firm in our views and forget the daily movements. The next bit of news which I predict for next week will make this fly again ... vlad has to deliver the trial update or an update on long term funding !!!!
Crunch ... is that a fact or hearsay? I would also expect big pharma to be watching the hemo story very carefully especially once trials on CART start. Astra is expanding fast in the cancer area so wouldn't be surprised are circling ...
OMG, this is chump change at £20m MCAP !!! If I had £5m I would buy all the stock and launch a hostile takeover then do a raft of marketing updates and bring on a new CEO and Head of BD !!!
Chris ...Yes I totally. Traders are welcome to create momentum but we really need a wider base of LTH that builds a position and stays for 12 months. This stock has been so abused and depressed because of bad decisions by our great CEO. Nevertheless, it is now sitting at a price that is the same as pre funded, pre ind approval, pre updates on CBR .... WTF is going on here.
I will be honest, I feel a little upset that we have been here 5 years and still at a loss and anyone else who is aware of the CART Approval and fully funded for trials, can now inject money at 1.7p and virtually be guaranteed this will double or triple in a few months !!! It was 7p 3 months ago before the shorters attacked.
Some of my family have been advised of this amazing opportunity but the risk vrs reward on this stock at this price is truly mind boggling ... once people realise what the upside is here it will move !!!
Jackdaw ... I have never seen a company so suppressed and manipulated by shorters and traders as hemo. Whatever your number of shares, it doesnt matter since I think the bottom has been reached and a reversal is now coming. Keep the faith my friend, when this blows, it will move fast !!!.
Rome was not built in a day. We all know because of hatred towards vlad and his bad decisions, this price is being artificially supressed. I feel before the end of March we will get an update on CART or CBR and everyone will be scrambling to get shares (and yes I know there are an extra 166 million to absorb).
If i had the money I would definately buy more. Best to ignore the noise and just wait for news. This is that quiet period when the stock was at 1.2p in Jan 2023 and then news came and it rocketed. I am totally comfortable to wait for trial news and let the market absorb and the price will readjust.
It's always the same with hemo ... no news and the price stays stagnant and then news suddenly arrives and its rockets. Good luck all
Dhub ... If i had money and not as many as shares as I already have, I would have also bought a few million more but I cannot take any more risk sadly. Well done on buying more and I hope some of these shorters that sold start buying once they feel comfortable that they have shafted a cancer saving company. I feel we are back in days of 2023 when we should be seriously celebrating 5p+ as we all expected.